Education
About Us
Working with TipRanks
Follow Us
COSCIENS Biopharma (TSE:CSCI)
TSX:CSCI
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 4.50M | $ 5.64M | $ 5.26M | $ 3.65M | $ 532.00K |
| Gross Profit | $ 4.28M | $ 5.48M | $ 5.17M | $ 1.33M | $ 122.00K |
| Operating Income | $ -18.01M | $ -15.38M | $ -8.67M | $ -5.92M | $ -9.54M |
| EBITDA | $ -17.99M | $ -15.36M | $ 2.85M | $ -5.69M | $ -9.23M |
| Net Income | $ -3.55M | $ 3.24M | $ 2.64M | $ 1.46M | $ -6.04M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 34.02M | $ 50.61M | $ 65.30M | $ 24.27M | $ 7.84M |
| Total Assets | $ 37.02M | $ 56.03M | $ 80.10M | $ 37.28M | $ 19.98M |
| Total Debt | $ 3.39M | $ 3.86M | $ 161.00K | $ 2.38M | $ 903.00K |
| Net Debt | $ -33.74M | $ -50.43M | $ -65.14M | $ -21.89M | $ -6.93M |
| Total Liabilities | $ 18.82M | $ 20.25M | $ 27.12M | $ 24.07M | $ 22.44M |
| Stockholders' Equity | $ 18.20M | $ 35.78M | $ 52.99M | $ 13.21M | $ -2.46M |
| Cash Flow | |||||
| Free Cash Flow | $ -17.14M | $ -13.69M | $ -9.22M | $ -4.75M | $ -10.72M |
| Operating Cash Flow | $ -17.12M | $ -13.68M | $ -8.58M | $ -4.13M | $ -10.72M |
| Investing Cash Flow | $ 528.00K | $ -12.00K | $ -658.00K | $ 56.00K | $ 50.00K |
| Financing Cash Flow | $ -151.00K | $ -118.00K | $ 51.04M | $ 20.47M | $ 3.89M |